3 Key Takeaways From The RFK Jr. Hearings
Experts told Law360 that Health and Human Services Secretary Robert F. Kennedy Jr. appears to be avoiding “politically unsavory” issues and focusing on more popular health policies across his hearings this week. Here, Law360 looks at experts' three takeways.
FDA Signals Flexibility In Pitch To Reduce Animal Testing
New federal guidance points to regulator flexibility on appropriate alternatives to using animals for testing drug safety.
Biotechs Rev Up To Go Public, Spurring Hope For The Sector
A smattering of biotech companies have signaled plans to go public in recent days, kicking off what industry insiders expect to be a busy spring and summer for the public markets. Despite a rocky past few weeks for geopolitics, industry insiders are hopeful that 2026's initial public offering market could trigger a steady return to normalcy.
3 Key Takeaways From The RFK Jr. Hearings
Experts told Law360 that Health and Human Services Secretary Robert F. Kennedy Jr. appears to be avoiding “politically unsavory” issues and focusing on more popular health policies across his hearings this week. Here, Law360 looks at experts' three takeways.
FDA Signals Flexibility In Pitch To Reduce Animal Testing
New federal guidance points to regulator flexibility on appropriate alternatives to using animals for testing drug safety.
Biotechs Rev Up To Go Public, Spurring Hope For The Sector
A smattering of biotech companies have signaled plans to go public in recent days, kicking off what industry insiders expect to be a busy spring and summer for the public markets. Despite a rocky past few weeks for geopolitics, industry insiders are hopeful that 2026's initial public offering market could trigger a steady return to normalcy.
Expert Analysis
The Ninth Circuit's recent decision in Fresenius v. Bonta suggests that businesses have a First Amendment right to... (more story)
The outlook for rural hospitals has grown more concerning, as recent policy and regulatory developments are decrea... (more story)
Several pending cases target the issue of whether generative AI may appropriately replace human professional decis... (more story)
Deals & Corporate Governance More
The full Federal Circuit on Wednesday rejected Sarepta Therapeutics Inc.'s bid for a rehearing after a panel's decision revived a University of Pennsylvania gene therapy patent that is licensed by clinical-sta... (more story)
A Delaware federal court voided a life insurance policy as an unlawful wager on a now-deceased Florida woman's life, finding that Ameritas Life Insurance Corp. is entitled to retain the policy's $10 million de... (more story)
Healthcare-focused real estate investment trust National Healthcare Properties began trading Wednesday after raising $462 million in an initial public offering guided by Paul Weiss, Greenberg Traurig LLP, Sidl... (more story)
Retirement plan participants have hit hospital system Providence Health & Services with a proposed class action accusing the Washington-based nonprofit of losing nearly $70 million in assets by sticking with a... (more story)
President Donald Trump recently announced 100% tariffs on certain imported pharmaceutical products, with opportunities for drug companies to lower their tariff rates to zero, but questions remain about the req... (more story)
In this month's bid protest roundup, Brian Doll at MoFo delves into three recent decisions from the Government Accountability Office about the evidentiary standards necessary to sustain a protest, discussions ... (more story)
Digital Health & Technology More
A San Francisco-based healthcare technology company failed to deliver on promises it would consolidate a Catholic health system's data under a unified platform, breaching a projected $32 million service agreem... (more story)
Zepp Health has hit Oura Health with a lawsuit in the Eastern District of Texas accusing the Finnish company of infringing a series of patents on wearable fitness devices, the latest salvo in a wider patent fi... (more story)
A San Diego-based healthcare technology services company has accused Commure Inc. of stealing trade secrets to launch competing cloud-based software, framing the alleged conduct as an instance of a large compa... (more story)
An Illinois federal judge has refused to cut wiretap and negligence claims from a proposed class action accusing telehealth provider Nourish Inc. of deploying tracking tools that illegally transmitted website ... (more story)
The Seventh Circuit declined Tuesday to revive vaping interest groups' bid to halt enforcement of a Wisconsin law banning sales of e-cigarettes that aren't approved by the U.S. Food and Drug Administration, fi... (more story)
A pending motion to dismiss the Michigan attorney general's drug-pricing case against multiple pharmacy benefit managers does not preclude the PBMs from handing over agreements between PBMs and pharmacies to t... (more story)
Policy & Compliance More
A Washington federal court has ordered the Trump administration to produce records underlying its decision to bar transgender individuals from serving in the U.S. military, rejecting a distinction the administ... (more story)
Insurers Humana Inc. and Molina Healthcare Inc. urged a federal judge to turn down a group of generic-drug makers' request for an immediate trip to the Third Circuit, arguing the drugmakers' bid for a second c... (more story)
Law360 Healthcare Authority looks at the U.S. Supreme Court's rejection of a petition by Johnson & Johnson challenging the certification of an investor class, a Pennsylvania state court's recognition of a cons... (more story)
There have been more intellectual property bills floated in Congress that are supportive of copyright rights than patent rights, according to a new report looking at how lawmakers treat the IP system.
A former Amgen Inc. employee filed a proposed class action in California federal court Tuesday alleging the biotech company discriminatorily imposes an "egregiously high" $150-a-month surcharge on employees wh... (more story)
A San Diego woman has pled guilty in California federal court to billing Medicare for nearly $51 million in fake prescriptions and trying to hide the scheme through money laundering and kickbacks to doctors.